The Role of NF-?B, PPAR-a, and PPAR-? in Older Adults with Metabolic Syndrome

Abstract

The etiopathogenesis of metabolic syndrome (MetS) has not been fully understood yet, and chronic low-grade inflammation is thought to be associated with the development of complications related to MetS. We aimed to investigate the role of Nuclear factor Kappa B ( NF-?B ), Peroxisome Proliferator-Activated Receptor- a and ? (PPAR-a, and PPAR-?) which are the main markers of inflammation in older adults with MetS. A total of 269 patients aged=18, 188 patients with MetS who met the diagnostic criteria of the International Diabetes Federation, and 81 controls who applied to geriatrics and general internal medicine outpatient clinics for various reasons were included in the study. Patients were separated into four groups: young with MetS (< 60, n=76), elderly with MetS (=60, n=96), young control (< 60, n=31), elderly controls (=60, n=38). Carotid intima-media thickness (CIMT) and NF-?B , PPAR-a, and PPAR-? plasma levels were measured in all of the participants. Age and sex distribution were similar between MetS and control groups. C-reactive protein (CRP), NF-?B levels (p=0.001) and CIMT (p<0,001) of MetS group were significantly higher than in the control groups. On the other hand, the PPAR-? (p=0.008) and PPAR-a (p=0.003) levels were significantly lower in MetS. ROC analysis revealed that the NF-?B, PPAR-a, and PPAR-? could be used to indicate MetS in younger adults (AUC: 0.735, p<0.000; AUC: 0.653, p=0.003), whereas it could not be an indicator in older adults (AUC: 0.617, p=0.079; AUC:0.530, p=0.613). It seems that these markers have important roles in MetS-related inflammation. In our results, suggest that the indicator feature of NF-?B , PPAR-a and PPAR-? in recognizing MetS in young individuals is lost in older adults with Mets.